Risk factors for perianeurysmal vasogenic oedema (pavo) following embolization therapy: literature review.

Autor: Mensah EO; School of Clinical Medicine, University of Cambridge, Cambridge, CB2 0SP, UK., Abusellie AR; School of Clinical Medicine, University of Cambridge, Cambridge, CB2 0SP, UK., Pringle C; Department of Neurosurgery, Royal Preston Hospital, Preston, PR2 9HT, UK., Emsley H; Department of Neurology, Royal Preston Hospital, Preston, PR2 9HT, UK., Alalade AF; Department of Neurosurgery, Royal Preston Hospital, Preston, PR2 9HT, UK. andrew.alalade@gmail.com., Roberts GA; Department of Neurosurgery, Royal Preston Hospital, Preston, PR2 9HT, UK.
Jazyk: angličtina
Zdroj: Neurosurgical review [Neurosurg Rev] 2023 Oct 09; Vol. 46 (1), pp. 266. Date of Electronic Publication: 2023 Oct 09.
DOI: 10.1007/s10143-023-02168-0
Abstrakt: Perianeurysmal vasogenic oedema (PAVO) is a rare complication associated post-embolisation of intracranial aneurysms. The prevalence, risk factors predisposing to susceptibility, and pathologic mechanisms underlying this process are not clearly understood. Since this complication may be associated with poor clinical outcomes, the authors designed this study to describe possible risk factors, underlying mechanisms, and management of PAVO through published case reports. Developing a priori protocol according to PRISMA guidelines, we searched MEDLINE/PubMed, Embase and Web of Science to identify case studies and reports of adult patients with intracranial aneurysms who developed perianeurysmal oedema following coil embolization therapy. Data extracted from these studies included patient demographics, aneurysm characteristics, coil type, PAVO characteristics, treatment, and outcomes. Quality was assessed using a standardized tool. 21 eligible studies of acceptable quality were identified, comprising 40 unique cases from 9 countries. The mean patient age was 56.4 years and 25 (62.5%) were female. Aneurysm size ranged from 6 to 30 mm, with a mean size of 15.2 mm; only 6 (15%) of cases were giant intracranial aneurysm (≥ 25 mm). The more frequent locations of intracranial aneurysms associated with PAVO were the ICA (50%) and posterior circulation (32.5%), with 7.5% and 10% of cases occurring in MCA and anterior circulation, respectively. 16 cases (40%) were treated with bare platinum coils, and 14 (35%) with a combination of BPCs and bioactive coils; in 10 cases (25%), the coil type was not mentioned. PAVO presented between 0 days and 8 years of coil embolization, with 23 (57.5% cases) presenting symptomatically in relation to brain region affected. Management strategies for PAVO included conservative, steroids, re-embolization, clipping, stenting, parent artery occlusion either as monotherapy or as combination therapy. Of reported studies, 26 treated cases (65%) resolved, with 8 (20%) remaining stable, and 4 (10%) deteriorating. PAVO can be associated with small or large intracranial aneurysms, bare and bioactive platinum coils, and all regions of the intracranial circulation. The understanding of the risk factors of this complication lies in the underlying mechanisms, which will ultimately guide appropriate patient follow-up and subsequent optimal management.
(© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: